Prospective longitudinal study of psychological sequelae, self-perception of body image, and quality of life in severe cutaneous adverse drug reactions: a case-control study
Open Access
- 29 May 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1774494
Abstract
Background: Severe cutaneous adverse drug reactions (SCARs) are associated with mental health sequelae and reduced quality of life. However, existing research is limited by small retrospective cohorts, overrepresentation of high-income countries, lighter skin tones, inadequate controls, and a paucity of prospective longitudinal case-control studies assessing the psychological sequelae in SCAR. Objective: This study aimed to prospectively determine and compare the longitudinal trajectories of psychological sequelae in patients with SCAR and controls. Methods: Between June 2020 and October 2023, SCAR cases and matched controls were recruited. The following validated instruments were used for assessments: (1) the MINI International Neuropsychiatric Interview to assess depression and suicide risk; (2) the Kessler Psychological Distress Scale (K10) to determine pre-existing depression; (3) the Cutaneous Body Image (CBI) scale to measure self-perception of body image; and (4) the Dermatology quality life index (DQLI) to measure the impact of SCAR on health-related quality of life (QoL). Assessments were conducted at admission (baseline or t 0 ), 6 months ( t 1 ), and 12 months ( t 2 ) after the development of SCARs. Results: Total of 47 SCAR cases (8 SJS/TEN, 35 DRESS, and 4 GBFDE) and 30 controls were recruited. All had Fitzpatrick skin types ≥III. Cases had significantly higher prevalence of depression [21/47 (45%) vs. 4/30 (13.3′%), p = 0.006] and suicide risk [12/21 (57%) vs. 1/4 (25%), p = 0.012] compared to controls at t 0. This was maintained at t 1 and t 2 . Of 45 cases, 36 (80%) had severe negative self-perception, significantly more than in controls [10/18 (56%), p = 0.023] at t 0 . Among the cases, 20% continued to experience this negative self-perception, while 9% experienced a deterioration over time. Only one showed persistent negative self-perception among controls. At t 0, cases had significantly impaired QoL compared to controls , with a median (IQR) DLQI score of [9.3 (4–15) vs. 1.5 (0–3), p < 0.001]. However, this effect was lost over time. A major limitation of the study was the high rate of loss-to-follow-up due to coronavirus disease 2019 (COVID-19). Conclusion: SCARs were found to be associated with a high risk of depression, suicide, impaired QoL, and severe negative self-perception compared to controls. SCAR patients demonstrated persistent or worsening impairments at 6 months and relapses at 12 months. These findings highlight the ongoing psychosocial burden of SCARs and the need for integrated mental health support.Keywords
Funding Information
- South African National Research Foundation (121278)
- NIH (01AI154659)
- NIH (R01AI152183)
- NIH (R01HG010863)
- South African Medical Research Council
- National Institute of Allergy and Infectious Diseases of the National Institutes of Health (R01AI152183)
- European Commission (TMA2017SF-1981)
- National Research Foundation (NRF) SARChI Chair in Dermatology and Toxicology grant
- South African Medical Research Council
This publication has 57 references indexed in Scilit:
- Long-term Physical and Psychological Outcomes of Stevens-Johnson Syndrome/Toxic Epidermal NecrolysisJAMA Dermatology, 2021
- Lower-than-predicted mortality in a predominantly HIV-infected population with epidermal necrolysis regardless of HIV status: implications and challenges for interventional studiesThe Journal of Allergy and Clinical Immunology: In Practice, 2018
- SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and TranslationThe Journal of Allergy and Clinical Immunology: In Practice, 2018
- Severe Delayed Cutaneous and Systemic Reactions to Drugs: A Global Perspective on the Science and Art of Current PracticeThe Journal of Allergy and Clinical Immunology: In Practice, 2017
- Severe antiretroviral‐associated skin reactions in South African patients: a case series and case–control analysisPharmacoepidemiology and Drug Safety, 2016
- Acute generalized exanthematous pustulosis (AGEP): A review and updateJournal of the American Academy of Dermatology, 2015
- Comments on: DRESS syndromeJournal of the American Academy of Dermatology, 2014
- DRESS syndrome associated with HHV-6 reactivationEuropean Journal of Internal Medicine, 2003
- Screening for Serious Mental Illness in the General PopulationArchives of General Psychiatry, 2003
- Clinical Classification of Cases of Toxic Epidermal Necrolysis, Stevens-Johnson Syndrome, and Erythema MultiformeArchives of Dermatology, 1993